---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-183411"
form_type: "8-K"
ticker: "ZBH"
cik: "0001136869"
company_name: "ZIMMER BIOMET HOLDINGS, INC."
filed_at: "2026-04-28T23:59:59+00:00"
generated_at: "2026-05-15T02:43:33.989926+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ZBH Q1 net sales $2.09B (+9.3% reported); adj EPS $2.09 (+15.5%); raises FY adj EPS guidance to $8.40-$8.55

## Summary
- Q1 net sales $2.087B, +9.3% reported, +6.8% constant currency, +2.9% organic constant currency.
- GAAP diluted EPS $1.22 (+34.1%); adjusted diluted EPS $2.09 (+15.5%).
- Operating cash flow $359.4M, free cash flow $245.9M in Q1.
- Repurchased $250M of shares during the first quarter.
- FY2026 adj EPS guidance raised to $8.40-$8.55 (from $8.30-$8.45); organic CC revenue guidance unchanged at 1-3%.

## SEC filing metadata
- accession: 0001193125-26-183411
- form_type: 8-K
- ticker: ZBH
- cik: 0001136869
- company_name: ZIMMER BIOMET HOLDINGS, INC.
- filed_at: 2026-04-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1136869/000119312526183411/0001193125-26-183411-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1136869/000119312526183411/zbh-20260428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-183411
- JSON: https://secwatch.observer/filing/0001193125-26-183411.json
- Plain text: https://secwatch.observer/filing/0001193125-26-183411.txt

## Key facts
- Earnings Releases
  ZIMMER BIOMET HOLDINGS, INC. reported the fiscal year ending December 31, 2026 results: EPS $8.40 - $8.55. Guidance raised.
  - Period: the fiscal year ending December 31, 2026
  - EPS: $8.40 - $8.55
  - Guidance: raised
  - Result: guidance update
  source text: The Company is updating its full-year 2026 financial guidance as follows:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1136869/000119312526183411/0001193125-26-183411-index.htm
- Earnings Releases
  ZIMMER BIOMET HOLDINGS, INC. reported the quarter ended March 31, 2026 results: revenue $2.087 billion, net income $238.1 million, EPS $1.22.
  - Period: the quarter ended March 31, 2026
  - Revenue: $2.087 billion
  - Net income: $238.1 million
  - EPS: $1.22
  - Result: reported results
  source text: The Company reported first quarter net sales of $2.087 billion, an increase of 9.3% over the prior year period, an increase of 6.8% on a constant currency 1 basis and an increase of 2.9% on an organic constant currency 1 basis.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1136869/000119312526183411/0001193125-26-183411-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.